184 related articles for article (PubMed ID: 29029206)
1. Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity.
Bertels F; Marzel A; Leventhal G; Mitov V; Fellay J; Günthard HF; Böni J; Yerly S; Klimkait T; Aubert V; Battegay M; Rauch A; Cavassini M; Calmy A; Bernasconi E; Schmid P; Scherrer AU; Müller V; Bonhoeffer S; Kouyos R; Regoes RR;
Mol Biol Evol; 2018 Jan; 35(1):27-37. PubMed ID: 29029206
[TBL] [Abstract][Full Text] [Related]
2. Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup.
Bachmann N; Turk T; Kadelka C; Marzel A; Shilaih M; Böni J; Aubert V; Klimkait T; Leventhal GE; Günthard HF; Kouyos R;
Retrovirology; 2017 May; 14(1):33. PubMed ID: 28535768
[TBL] [Abstract][Full Text] [Related]
3. Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.
Blanquart F; Wymant C; Cornelissen M; Gall A; Bakker M; Bezemer D; Hall M; Hillebregt M; Ong SH; Albert J; Bannert N; Fellay J; Fransen K; Gourlay AJ; Grabowski MK; Gunsenheimer-Bartmeyer B; Günthard HF; Kivelä P; Kouyos R; Laeyendecker O; Liitsola K; Meyer L; Porter K; Ristola M; van Sighem A; Vanham G; Berkhout B; Kellam P; Reiss P; Fraser C;
PLoS Biol; 2017 Jun; 15(6):e2001855. PubMed ID: 28604782
[TBL] [Abstract][Full Text] [Related]
4. Validation of CD4
Cassenote AJF; Grangeiro A; Escuder MM; Abe JM; Segurado AAC
BMC Infect Dis; 2018 Dec; 18(1):617. PubMed ID: 30514215
[TBL] [Abstract][Full Text] [Related]
5. Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.
Herbeck JT; Müller V; Maust BS; Ledergerber B; Torti C; Di Giambenedetto S; Gras L; Günthard HF; Jacobson LP; Mullins JI; Gottlieb GS
AIDS; 2012 Jan; 26(2):193-205. PubMed ID: 22089381
[TBL] [Abstract][Full Text] [Related]
6. No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.
Helleberg M; Kronborg G; Larsen CS; Pedersen G; Pedersen C; Obel N; Gerstoft J
HIV Med; 2013 Jul; 14(6):362-9. PubMed ID: 23433434
[TBL] [Abstract][Full Text] [Related]
7. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.
Alizon S; von Wyl V; Stadler T; Kouyos RD; Yerly S; Hirschel B; Böni J; Shah C; Klimkait T; Furrer H; Rauch A; Vernazza PL; Bernasconi E; Battegay M; Bürgisser P; Telenti A; Günthard HF; Bonhoeffer S;
PLoS Pathog; 2010 Sep; 6(9):e1001123. PubMed ID: 20941398
[TBL] [Abstract][Full Text] [Related]
8. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
9. Short communication: HIV type 1 subtype BF leads to faster CD4+ T cell loss compared to subtype B.
Tarosso LF; Sanabani SS; Ribeiro SP; Sauer MM; Tomiyama HI; Sucupira MC; Diaz RS; Sabino EC; Kalil J; Kallas EG
AIDS Res Hum Retroviruses; 2014 Feb; 30(2):190-4. PubMed ID: 23906381
[TBL] [Abstract][Full Text] [Related]
10. Per-pathogen virulence of HIV-1 subtypes A, C and D.
Bouman JA; Venner CM; Walker C; Arts EJ; Regoes RR
Proc Biol Sci; 2023 May; 290(1998):20222572. PubMed ID: 37161335
[TBL] [Abstract][Full Text] [Related]
11. Association between HIV genotype, viral load and disease progression in a cohort of Thai men who have sex with men with estimated dates of HIV infection.
Leelawiwat W; Pattanasin S; Sriporn A; Wasinrapee P; Kongpechsatit O; Mueanpai F; Tongtoyai J; Holtz TH; Curlin ME
PLoS One; 2018; 13(7):e0201386. PubMed ID: 30063722
[TBL] [Abstract][Full Text] [Related]
12. Virus-induced target cell activation reconciles set-point viral load heritability and within-host evolution.
Hool A; Leventhal GE; Bonhoeffer S
Epidemics; 2013 Dec; 5(4):174-80. PubMed ID: 24267873
[TBL] [Abstract][Full Text] [Related]
13. Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa.
Gray CM; Williamson C; Bredell H; Puren A; Xia X; Filter R; Zijenah L; Cao H; Morris L; Vardas E; Colvin M; Gray G; McIntyre J; Musonda R; Allen S; Katzenstein D; Mbizo M; Kumwenda N; Taha T; Karim SA; Flores J; Sheppard HW
AIDS Res Hum Retroviruses; 2005 Apr; 21(4):285-91. PubMed ID: 15943570
[TBL] [Abstract][Full Text] [Related]
14. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
[TBL] [Abstract][Full Text] [Related]
15. Characterization of GBV-C infection in HIV-1 infected patients.
Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
[TBL] [Abstract][Full Text] [Related]
16. A highly virulent variant of HIV-1 circulating in the Netherlands.
Wymant C; Bezemer D; Blanquart F; Ferretti L; Gall A; Hall M; Golubchik T; Bakker M; Ong SH; Zhao L; Bonsall D; de Cesare M; MacIntyre-Cockett G; Abeler-Dörner L; Albert J; Bannert N; Fellay J; Grabowski MK; Gunsenheimer-Bartmeyer B; Günthard HF; Kivelä P; Kouyos RD; Laeyendecker O; Meyer L; Porter K; Ristola M; van Sighem A; Berkhout B; Kellam P; Cornelissen M; Reiss P; Fraser C; ;
Science; 2022 Feb; 375(6580):540-545. PubMed ID: 35113714
[TBL] [Abstract][Full Text] [Related]
17. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa.
Gottlieb GS; Sow PS; Hawes SE; Ndoye I; Redman M; Coll-Seck AM; Faye-Niang MA; Diop A; Kuypers JM; Critchlow CW; Respess R; Mullins JI; Kiviat NB
J Infect Dis; 2002 Apr; 185(7):905-14. PubMed ID: 11920314
[TBL] [Abstract][Full Text] [Related]
18. HIV RNA level in early infection is predicted by viral load in the transmission source.
Hecht FM; Hartogensis W; Bragg L; Bacchetti P; Atchison R; Grant R; Barbour J; Deeks SG
AIDS; 2010 Apr; 24(7):941-5. PubMed ID: 20168202
[TBL] [Abstract][Full Text] [Related]
19. Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 x 10(6) cells/l.
Thiébaut R; Pellegrin I; Chêne G; Viallard JF; Fleury H; Moreau JF; Pellegrin JL; Blanco P
AIDS; 2005 Jan; 19(1):53-61. PubMed ID: 15627033
[TBL] [Abstract][Full Text] [Related]
20. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
